Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels (Q40200929)
Jump to navigation
Jump to search
scientific article published on December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels |
scientific article published on December 2006 |
Statements
1 reference
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels (English)
1 reference
Fred R Hirsch
1 reference
Marileila Varella-Garcia
1 reference
Barbara A Helfrich
1 reference
David Raben
1 reference
Dan Gustafson
1 reference
Daniel C Chan
1 reference
Lynne Bemis
1 reference
Chris Coldren
1 reference
Anna Barón
1 reference
Chan Zeng
1 reference
Wilbur A Franklin
1 reference
Adi Gazdar
1 reference
John Minna
1 reference
Paul A Bunn
1 reference
1 December 2006
1 reference
1 reference
Identifiers
1 reference